Wave Photonics eyes Singapore as Asian quantum hub

Wave Photonics' Singapore pivot is geopolitical hedging, not market expansion. A UK PIC startup already tethered to Hon Hai Research Institute in Taiwan, China still needs a second node because US-EU export controls on quantum equipment are compressing the single-axis "design in Britain, build in Taiwan, China" model. Singapore's value is tripartite: local foundry capacity, NRF/A*STAR quantum funding, and geographic arbitrage adjacent to Malaysia's packaging cluster. The technical cascade outweighs the headline. PIC is the shared substrate for photonic quantum computing, QKD, and co-packaged optics. Routing the EDA-to-fab-to-test chain through Southeast Asia creates a parallel SG-MY axis that pulls in Malaysian test houses and Vietnamese assembly, decoupling supply from the US-Taiwan, China corridor. The real compliance risk isn't Singaporean regulation—it's BIS Entity List spillover. If Wave's EDA stack hits quantum-IP export restrictions, Singapore becomes a compliance buffer, but at the cost of dual-jurisdiction IP leakage exposure. The competitive threat isn't PsiQuantum or ORCA. It's Tower Semiconductor and GlobalFoundries bolting quantum-grade nodes onto classical PIC lines. Hon Hai will almost certainly accelerate in-house PIC R&D to reduce Wave dependency. 12-24 month tail: a dedicated quantum PIC line in Singapore by mid-2026; a compliance-clean APAC product spinout from Wave; Malaysia upgrading from packaging to full-process fab. The UK quantum strategy quietly shifts to dual-jurisdiction parallelism.